Onward Medical N.V.
Develops spinal stimulation therapies to restore movement for people with spinal cord injury.
ONWD | AS
Overview
Corporate Details
- ISIN(s):
- NL0015000HT4
- LEI:
- 9845007A2CC4C8BFSB80
- Country:
- Netherlands
- Address:
- Schimmelt 2, 5611ZX Eindhoven
- Website:
- https://www.onwd.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Onward Medical N.V. is a medical technology company developing therapies to restore movement, function, and independence for people with spinal cord injury (SCI). The company's core technology is ARC Therapy, a platform that uses targeted, programmed electrical stimulation of the spinal cord. Its portfolio includes the ARCEX System, a non-invasive, external device cleared by the FDA for use in the United States to improve hand and arm function in individuals with SCI. Onward is also advancing investigational implantable systems, including ARCIM and ARCBCI, which may be combined with a brain-computer interface (BCI). The company's research and development is supported by multiple FDA Breakthrough Device Designations and a portfolio of nearly 400 issued or pending patents.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 07:30 |
Regulatory News Service
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blo…
|
English | 205.3 KB | ||
| 2025-09-02 07:42 |
Interim Report
ONWARD Medical N.V., Halfjaarlijkse financiële verslaggeving
|
English | 8.8 MB | ||
| 2025-09-02 07:30 |
Earnings Release
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the Fi…
|
English | 208.1 KB | ||
| 2025-08-18 18:30 |
Regulatory News Service
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Stu…
|
English | 208.3 KB | ||
| 2025-07-07 11:20 |
Board/Management Information
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison…
|
English | 154.2 KB | ||
| 2025-06-12 07:52 |
Post-Annual General Meeting Information
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
|
English | 138.1 KB | ||
| 2025-06-11 19:00 |
Post-Annual General Meeting Information
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
|
English | 138.1 KB | ||
| 2025-05-01 06:28 |
Pre-Annual General Meeting Information
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders a…
|
English | 115.4 KB | ||
| 2025-04-30 17:30 |
Pre-Annual General Meeting Information
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders a…
|
English | 115.4 KB | ||
| 2025-04-28 08:30 |
Report Publication Announcement
ONWARD Medical Announces Release of 2024 Annual Report
|
English | 104.0 KB | ||
| 2025-04-28 08:09 |
Annual Report (ESEF)
ONWARD Medical N.V., Jaarlijkse financiële verslaggeving
|
English | 8.0 MB | ||
| 2025-04-01 07:30 |
Earnings Release
ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice…
|
French | 291.0 KB | ||
| 2024-12-20 07:51 |
Regulatory News Service
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization …
|
English | 128.5 KB | ||
| 2024-12-19 18:00 |
Regulatory News Service
ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de…
|
French | 155.3 KB | ||
| 2024-10-29 07:28 |
Share Issue/Capital Change
ONWARD® Medical Publishes Closing of Bookbuild Offering
|
English | 89.0 KB |
Automate Your Workflow. Get a real-time feed of all Onward Medical N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Onward Medical N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-19 | G.R. Courtine | Non-Executive member | Other | 451,822 | N/A |
| 2023-01-03 | D.L. Marver | Non-Executive member | Other | 385,000 | N/A |
| 2022-12-23 | F.A. Colen | Non-Executive member | Other | 47,740 | N/A |
| 2022-11-18 | D.L. Marver | Non-Executive member | Other | 954,814 | N/A |
| 2022-09-29 | V.E. Riefberg | Non-Executive member | Other | 16,000 | N/A |
| 2021-12-15 | J.K. Ohrstrom | Non-Executive member | Other | 38,000 | N/A |
| 2021-10-22 | D.L. Marver | Non-Executive member | Other | 6,765 | N/A |
